Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
December 2015 onwards
Submit An Event
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
First Made-in-Singapore Cancer Drug Enters Clinical Testing
The drug prevents cancer progression and paves the way for new advancements in cancer therapeutics.
04 Mar 2014 - 06 Mar 2014
Vaccine World Summit India 2014
10 Mar 2014 - 14 Mar 2014
Milton Keynes, UK
5-day Complete Hands-on GC & GC-MS training course
11 Mar 2014 - 13 Mar 2014
Cambridge, MA, USA
Clin Tech 2014
11 Mar 2014 - 03 Apr 2014
Peptide and Protein Characterization with LC/M
17 Mar 2014 - 20 Mar 2014
Dubai International Convention and Exhibition Centre, Dubai
24 Mar 2014 - 25 Mar 2014
Silver Spring, MD, USA
Bioassays 2014: Scientific Approaches & Regulatory Strategies
24 Mar 2014 - 25 Mar 2014
Boston, MA, USA
4TH ANNUAL Biosimilar Conference
26 Mar 2014 - 28 Mar 2014
Beckenham, near London
Hands-on Tablet Development, including Pre-formulation, Formulation and Process Development
31 Mar 2014 - 01 Apr 2014
Paediatric Clinical Trials
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,400+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!